LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

HomeStock ListCharles River Laboratories International Inc

Charles River Laboratories International Inc

Open

240.06 -2.93

Overview

Share price change

24h

Current

Min

240

Max

245.5

Key metrics

By Trading Economics

Income

100M

187M

Sales

-13M

1B

P/E

Sector Avg

25.602

23.904

EPS

2.46

Profit margin

18.46

Employees

20,000

EBITDA

-16M

231M

Recommendations

By TipRanks

Rating Consensus

Buy

12 Months Forecast

+8.74 upside

Dividends

By Dow Jones

Next earnings

9 May 2024

Market Stats

By TradingEconomics

Market Cap

-282M

13B

Previous open

242.99

Previous close

240.06

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Charles River Laboratories International Inc chart

Related News

23 Mar 2024, 13:00 UTC

Top News

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

Peer Comparison

Price change

Charles River Laboratories International Inc forecast

Price Target

By TipRanks

8.74% upside

12 Months Forecast

Average 275.22 USD  8.74%

High 300 USD

Low 235 USD

Based on 10 Wall Street analysts offering 12 month price targets for Charles River Laboratories International Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

6

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

246.38 / 258.88 Support&Resistance

Short Team

Strong Bearish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.